Skip survey header

GMI Game-Based Survey - HCP


The Medical Information Department at Pfizer is conducting a survey to learn more about your recent experience requesting information about VYNDAQEL® (tafamidis meglumine) or VYNDAMAX™ (tafamidis).

Your feedback will be used to better understand how we can enable healthcare professionals (HCPs) to make informed decisions about Pfizer medications. All information you provide in this survey is anonymously collected and analyzed by BioCentric, Inc., an independent research agency.

This survey should take less than 10 minutes to complete.